RE: Ramping Fest31 Dec 2024 13:45
However, the letter of intent and the proposed licence agreement, first referenced in November 2021, remained non-binding, adding there was no assurance that the agreement would be finalised or generate significant revenue within the anticipated time frame, if at all.
"This final, time limited, extension has been granted to allow TheoremRx to complete their M&A transaction with a Nasdaq-listed company, which is required to enable execution of the sub-license of VAL201 to TheoremRx," said ValiRx chief executive officer Mark Eccleston.
Just like buying a ticket for the lottery then….. I’m not in here , still watching and waiting……. Got plenty of time to buy on any rise as I have been told Many times by a self proclaimed well read ,highly educated investor ,,……….30p+++++ is a no brainer